Latest Genvec Inc (GNVC) Headlines GenVec to Pr
Post# of 14
Posted On: 03/12/2014 9:41:20 PM
Latest Genvec Inc (GNVC) Headlines
GenVec to Present at 26th Annual ROTH Conference
PR Newswire - Mon Mar 03, 7:00AM CST
GenVec, Inc. (NASDAQ:GNVC) announced today that the Company will participate in the 26th Annual ROTH Conference being held March 9-12, 2014 in Dana Point, California. Douglas Swirsky, President and CEO of GenVec, will present a company overview on Monday, March 10, 2014 at 3:00 pm Pacific Daylight Time.
GenVec Achieves Third Milestone In Hearing And Balance Collaboration
PR Newswire - Thu Feb 13, 5:00AM CST
GenVec, Inc. (NASDAQ: GNVC) today announced that the company has achieved the third milestone in its collaboration with Novartis for the development of treatments for hearing and balance disorders. In January 2014, Novartis filed an Investigational New Drug (IND) application with the Food and Drug Administration (FDA) for the clinical development of CGF166, the lead product candidate under the collaboration. The IND was deemed effective on February 7, 2014 and this triggered a $2 million milestone payment to GenVec under the terms of the collaboration.
3 Biotech Stocks Under $10 Triggering Breakouts
at The Street - Fri Jan 03, 6:00AM CST
Keep an eye on these under-$10 biotech stocks.
AutoGrid and Big Data Energy Services Announce Strategic Partnership to Deliver Demand Response (DR) Capabilities to Texas' Largest Electric Providers
Marketwire - Thu Dec 19, 6:32AM CST
AutoGrid Systems, a leader in innovative solutions for the electricity and energy industry, is proud to announce a strategic partnership with Big Data Energy Services (BDES), a cloud-based service provider and consulting firm, to deliver services and technology that will allow electricity providers to reduce the cost of power for their customers while mitigating the risk of sharply higher prices in tight energy markets.
PowerCloud Systems and Common Sense Media Join Forces to Help Kids and Families Make Smart Choices Online
PR Newswire - Wed Dec 18, 7:00AM CST
PowerCloud Systems, a pioneer in cloud networking for the connected home, and Common Sense Media, the largest non-partisan, not-for-profit organization dedicated to helping kids thrive in a world filled with media and technology, today announced a partnership dedicated to facilitating easy access to age-appropriate Internet content in the home. PowerCloud Systems is the creator of Skydog(TM), the revolutionary home networking solution used by thousands of families to manage their connected lives by providing unprecedented visibility into, and management over, their home networks. This partnership will give Skydog users easy access to Common Sense Media's independent, age-based ratings and reviews of online media, based on developmental criteria from some of the nation's leading authorities, and provide a technical solution for the family to manage access to this media.
Pricing of Public Offerings, Agreements, and Stock Movements- Research Report on MiMedx Group, NPS Pharmaceuticals, VIVUS, Merrimack Pharmaceuticals, and GenVec
PR Newswire - Tue Dec 17, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
Bullish Stocks Radar: OCZ Technology Group, GenVec Inc, IAMGOLD Corp, Inc, Chevron Corporation
ACCESSWIRE - Thu Dec 12, 10:13AM CST
New York, December 12, 2013 / Accesswire / - Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for OCZ Technology Group Inc.(NASDAQ:OCZ), GenVec Inc(NASDAQ:GNVC), IAMGOLD Corp (USA)(NYSE:IAG), Chevron Corporation(NYSE:CVX).
GenVec Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 12, 6:50AM CST
GenVec, Inc. (NASDAQ: GNVC) today announced financial results for the third quarter and nine months ended September 30, 2013.
Nasdaq stocks posting largest volume increases
AP - Fri Sep 06, 5:07PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Five Star Equities Issues New Research Reports on GNVC, RMTI, SAI and SNDK
ACCESSWIRE - Thu Sep 05, 7:40AM CDT
Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
GenVec Board Restructures Operations and Withdraws Plan of Dissolution
PR Newswire - Wed Sep 04, 7:30AM CDT
GenVec, Inc. (NASDAQ: GNVC) today announced that its Board of Directors withdrew the Plan of Complete Liquidation and Dissolution for the Company previously adopted on May 24, 2013. The Company also announced that it will pursue a strategy focused on maximizing the value of its technology and assets, including its collaboration with Novartis to develop novel treatments for hearing loss.
Traders Get Bullish on Shares of GenVec, Shares Up 17.1% (GNVC)
Comtex SmarTrend(R) - Tue Jun 25, 11:36AM CDT
GenVec (NASDAQ:GNVC) is one of today's best performing penny stocks, up 17.1% to $0.41 on 1.1x average daily volume. GenVec has traded 301,000 shares thus far today, vs. average volume of 269,000 shares per day. The stock has outperformed the Dow (17.1% to the Dow's 0.7%) and outperformed the S&P 500 (17.1% to the S&P's 0.9%) during today's trading.
GenVec Q4 Net Loss Deepens
Eric Volkman, The Motley Fool - Motley Fool - Fri Mar 22, 4:51PM CDT
GenVec results for the company’s Q4 and fiscal 2012 have been released. For the quarter, revenue was $1.5 million, less than half the $3.4 million of the same period the previous year. Attributable net loss deepened over that time span,...
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
PR Newswire - Fri Mar 22, 6:58AM CDT
Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the fourth quarter and year ended December 31, 2012. For the year ended December 31, 2012, the Company reported a net loss of $14.1 million, or $1.09 per share, compared with a net loss of $7.4 million, or $0.58 per share, for the year ended December 31, 2011. GenVec ended the year with $15.3 million in cash, cash equivalents, and short-term investments.
GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
PR Newswire - Fri Mar 15, 7:00AM CDT
GenVec, Inc. (Nasdaq: GNVC) will report financial results for the fourth quarter and year ended December 31, 2012 on Friday, March 22, 2013, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the company's fourth quarter and 2012 financial results and 2013 business outlook.
GenVec to Present at 26th Annual ROTH Conference
PR Newswire - Mon Mar 03, 7:00AM CST
GenVec, Inc. (NASDAQ:GNVC) announced today that the Company will participate in the 26th Annual ROTH Conference being held March 9-12, 2014 in Dana Point, California. Douglas Swirsky, President and CEO of GenVec, will present a company overview on Monday, March 10, 2014 at 3:00 pm Pacific Daylight Time.
GenVec Achieves Third Milestone In Hearing And Balance Collaboration
PR Newswire - Thu Feb 13, 5:00AM CST
GenVec, Inc. (NASDAQ: GNVC) today announced that the company has achieved the third milestone in its collaboration with Novartis for the development of treatments for hearing and balance disorders. In January 2014, Novartis filed an Investigational New Drug (IND) application with the Food and Drug Administration (FDA) for the clinical development of CGF166, the lead product candidate under the collaboration. The IND was deemed effective on February 7, 2014 and this triggered a $2 million milestone payment to GenVec under the terms of the collaboration.
3 Biotech Stocks Under $10 Triggering Breakouts
at The Street - Fri Jan 03, 6:00AM CST
Keep an eye on these under-$10 biotech stocks.
AutoGrid and Big Data Energy Services Announce Strategic Partnership to Deliver Demand Response (DR) Capabilities to Texas' Largest Electric Providers
Marketwire - Thu Dec 19, 6:32AM CST
AutoGrid Systems, a leader in innovative solutions for the electricity and energy industry, is proud to announce a strategic partnership with Big Data Energy Services (BDES), a cloud-based service provider and consulting firm, to deliver services and technology that will allow electricity providers to reduce the cost of power for their customers while mitigating the risk of sharply higher prices in tight energy markets.
PowerCloud Systems and Common Sense Media Join Forces to Help Kids and Families Make Smart Choices Online
PR Newswire - Wed Dec 18, 7:00AM CST
PowerCloud Systems, a pioneer in cloud networking for the connected home, and Common Sense Media, the largest non-partisan, not-for-profit organization dedicated to helping kids thrive in a world filled with media and technology, today announced a partnership dedicated to facilitating easy access to age-appropriate Internet content in the home. PowerCloud Systems is the creator of Skydog(TM), the revolutionary home networking solution used by thousands of families to manage their connected lives by providing unprecedented visibility into, and management over, their home networks. This partnership will give Skydog users easy access to Common Sense Media's independent, age-based ratings and reviews of online media, based on developmental criteria from some of the nation's leading authorities, and provide a technical solution for the family to manage access to this media.
Pricing of Public Offerings, Agreements, and Stock Movements- Research Report on MiMedx Group, NPS Pharmaceuticals, VIVUS, Merrimack Pharmaceuticals, and GenVec
PR Newswire - Tue Dec 17, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
Bullish Stocks Radar: OCZ Technology Group, GenVec Inc, IAMGOLD Corp, Inc, Chevron Corporation
ACCESSWIRE - Thu Dec 12, 10:13AM CST
New York, December 12, 2013 / Accesswire / - Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for OCZ Technology Group Inc.(NASDAQ:OCZ), GenVec Inc(NASDAQ:GNVC), IAMGOLD Corp (USA)(NYSE:IAG), Chevron Corporation(NYSE:CVX).
GenVec Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 12, 6:50AM CST
GenVec, Inc. (NASDAQ: GNVC) today announced financial results for the third quarter and nine months ended September 30, 2013.
Nasdaq stocks posting largest volume increases
AP - Fri Sep 06, 5:07PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Five Star Equities Issues New Research Reports on GNVC, RMTI, SAI and SNDK
ACCESSWIRE - Thu Sep 05, 7:40AM CDT
Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
GenVec Board Restructures Operations and Withdraws Plan of Dissolution
PR Newswire - Wed Sep 04, 7:30AM CDT
GenVec, Inc. (NASDAQ: GNVC) today announced that its Board of Directors withdrew the Plan of Complete Liquidation and Dissolution for the Company previously adopted on May 24, 2013. The Company also announced that it will pursue a strategy focused on maximizing the value of its technology and assets, including its collaboration with Novartis to develop novel treatments for hearing loss.
Traders Get Bullish on Shares of GenVec, Shares Up 17.1% (GNVC)
Comtex SmarTrend(R) - Tue Jun 25, 11:36AM CDT
GenVec (NASDAQ:GNVC) is one of today's best performing penny stocks, up 17.1% to $0.41 on 1.1x average daily volume. GenVec has traded 301,000 shares thus far today, vs. average volume of 269,000 shares per day. The stock has outperformed the Dow (17.1% to the Dow's 0.7%) and outperformed the S&P 500 (17.1% to the S&P's 0.9%) during today's trading.
GenVec Q4 Net Loss Deepens
Eric Volkman, The Motley Fool - Motley Fool - Fri Mar 22, 4:51PM CDT
GenVec results for the company’s Q4 and fiscal 2012 have been released. For the quarter, revenue was $1.5 million, less than half the $3.4 million of the same period the previous year. Attributable net loss deepened over that time span,...
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
PR Newswire - Fri Mar 22, 6:58AM CDT
Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the fourth quarter and year ended December 31, 2012. For the year ended December 31, 2012, the Company reported a net loss of $14.1 million, or $1.09 per share, compared with a net loss of $7.4 million, or $0.58 per share, for the year ended December 31, 2011. GenVec ended the year with $15.3 million in cash, cash equivalents, and short-term investments.
GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
PR Newswire - Fri Mar 15, 7:00AM CDT
GenVec, Inc. (Nasdaq: GNVC) will report financial results for the fourth quarter and year ended December 31, 2012 on Friday, March 22, 2013, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the company's fourth quarter and 2012 financial results and 2013 business outlook.
(0)
(0)GenVec Inc. (GNVC) Stock Research Links
Scroll down for more posts ▼